It is clear that NHD13 thymocytes employ at least two different mechanisms of leukaemogenesis, and that each is sufficient for leukaemia to occur: (1) the expression of the oncogene Lyl1, and (2) the inhibition of cell competition mediated by EPHA3. This evidence concerns the gene LYL1 and leukemia.